Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Release of the Entero-pancreatic Hormone Somatostatin by Measuring Stable Co-secreted Prosomatostatin Moieties in the Plasma of Healthy Individuals - the PRO-SOma COla (PROSOCO) Study

NCT06121245 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.

NCT NCT06121245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06121245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Release of the Entero-pancreatic Hormone Somatostatin by Measuring Stable Co-secreted Prosomatostatin Moieties in the Plasma of Healthy Individuals - the PRO-SOma COla (PROSOCO) Study
Lead sponsor
University of Copenhagen
Phase
Not applicable
Overall status
Unknown status
Start date
September 13, 2023
Completion date
February 29, 2024
Enrollment
11 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy